This Advisory outlines how healthcare providers (i.e., obstetrician-gynecologists [OB-GYNs], primary care physicians, and other professionals who treat pregnant people) can take an active role in supporting the health of pregnant individuals who have OUD and their babies.

This document accompanies the Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants publication. It offers information about child welfare systems and what the health care provider's role is in developing a Plan of Safe Care.

The fourth supplemental resource to SAMHSA’s Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants publication. This document contains information for pregnant people with a substance use disorder and preparing to deliver.

This Advisory is based on TIP 39, Substance Use Disorder Treatment and Family Therapy. It surveys basic factors for programs and providers to consider when implementing family-related therapy approaches, goals and processes for conducting effective family counseling, and resources for further learning about family therapy techniques and models.

This newly updated Treatment Improvement Protocol (TIP) helps providers and administrators better understand how to include families in substance use disorder treatment and services. This TIP, first published in 2004, has been revised to reflect new research and developments.

This flyer provides information and tips for coping during a pandemic as well as resources for additional assistance.

This report highlights existing programs that address behavioral health disparities among Asian American, Native Hawaiian, and Pacific Islander boys and young men. It also outlines effective tools and best practices in working with this population.

This hepatitis C education training guide provides counselors and other clinical staff with a scripted plan to use with patients and their families in behavioral health treatment.

This brief highlights the relationship between substance use and suicide and gives an overview of the issue. It describes for state and tribal prevention professionals evidence-based programs that focus on substance use and suicide prevention.

This brief highlights issues specific to Asian American, Native Hawaiian, and Pacific Islander males. It provides clinicians with data on the prevalence of depression, suicide, and substance use disorders within these populations.